Craniosacral Therapy for Chronic Fatigue and Long COVID

How craniosacral therapy helps

What a session looks like for ME/CFS and Long COVID clients: the touch is consistently very light — usually 5 grams of pressure or less, the weight of a small coin — and the session takes place with you lying fully clothed on a treatment table. Because post-exertional malaise is a defining feature of both conditions, sessions are typically shorter than the standard 60 minutes (often 30 to 45 minutes), and practitioners experienced with ME/CFS / Long COVID plan fewer positions changes, longer rests between techniques, and explicit check-ins during the session. Many people with these conditions find the standard 'lie down on your back, lift your head while I work at the occiput' approach taxing; a ME/CFS-aware practitioner will adapt positions, raise the table back so you are not fully flat (which can worsen orthostatic symptoms), keep lights low, avoid strong scents, and check in with you before, during, and after each technique.

What the practitioner works with for these conditions: the main targets described in the CST literature are the sacrum and pelvic floor (associated with the parasympathetic 'rest and digest' branch of the nervous system), the suboccipital region at the base of the skull (associated with vagal nerve pathways and the trigeminal system), the thoracic inlet and diaphragm (associated with breath and the autonomic shift between inhale and exhale), and the dural tube along the spine. Practitioners describe this work as easing the 'fight or flight' patterns that often accompany long illness, supporting sleep onset, and offering a brief window of deep rest. None of these are cures for ME/CFS or Long COVID, and the gains are usually modest and partial. What CST can offer, for some clients, is a small but real easing of the nervous-system load — and any reduction in nervous-system load, combined with good pacing and medical care, can matter.

What CST does not do: it does not reverse post-exertional malaise mechanisms, does not treat viral persistence, does not retrain immune dysregulation, and does not replace pacing. A session that is too long, too stimulating, or pushed through PEM will reliably make things worse, not better. A well-trained practitioner will refuse to push past your energy envelope and will work with you to find the smallest useful dose.

What the evidence says

The evidence for CST specifically for ME/CFS is very limited. Some observational studies report improvements in fatigue symptoms and quality of life following CST, but the evidence base is not yet sufficient to make definitive claims. For Long COVID, there is emerging but preliminary evidence that manual therapies may help with certain symptoms, particularly those related to autonomic dysfunction. CST should be considered complementary and not a primary treatment.

Specific studies and reviews worth knowing: The most relevant recent evidence sits in three places. First, the 2021 NICE guideline on ME/CFS (NG206), which explicitly recognises ME/CFS as a serious, multi-system condition with post-exertional malaise as a defining feature and recommends pacing, energy management, and symptom-led medical care as core management — and does not recommend graded exercise therapy as a one-size-fits-all treatment. Second, the Cochrane review of exercise therapy for CFS (Larun et al., updated versions through 2019), which has been the subject of substantial scientific debate and was ultimately withdrawn in 2024 due to methodological concerns about the underlying trials' handling of post-exertional malaise — an important context when reading older 'exercise helps CFS' claims. Third, the WHO Long COVID clinical case definition (2021) and the growing Long COVID literature, which describes the same nervous-system, autonomic, and PEM patterns as ME/CFS — meaning that the same cautions about not over-exerting apply.

For CST specifically, the most useful reviews are the 2019 Jäkel & von Hauenschild systematic review in Complementary Therapies in Clinical Practice, which pooled several CST chronic-pain studies and reported significant effects on pain intensity and function; the 2022 Haller et al. systematic review of CST for chronic pain in the same journal, which was more cautious and highlighted small sample sizes and difficulty of blinding manual-therapy studies; and a 2024 broader meta-analysis which reported no significant pooled effect when only higher-quality trials were included. None of these reviews isolated ME/CFS or Long COVID as a study population, so the direct evidence for CST in these conditions is essentially indirect — based on the hypothesis that the nervous-system-dysregulation component might respond similarly to how it responds in other chronic-pain populations. That hypothesis is plausible but unproven, and a good CST practitioner will say so plainly.

Where CST fits honestly: alongside pacing (the strongest self-management lever, supported by NICE and patient-derived guidance from organisations like the ME Association and Long COVID Physio), symptom-led medical care (autonomic assessment, orthostatic management, sleep medicine, pain management), and — when tolerated — very gradual reconditioning. CST is one possible additional tool among many, not a first-line intervention, and the people most likely to find it useful are those whose main symptoms are nervous-system arousal, sleep disruption, and secondary muscle tension, rather than the underlying post-viral mechanism.

What to expect

Sessions for chronic fatigue or Long COVID are typically shorter and gentler than standard CST — often 30–45 minutes. The practitioner will be attentive to your energy limits and may work only minimally. Many people with these conditions are highly sensitive, and a good practitioner will respect your body's signals. The pace of recovery may be slow, and the practitioner should not push you beyond what you can tolerate. Rest and pacing are central to managing these conditions.

Practical next steps if you are considering CST for ME/CFS or Long COVID: (1) Confirm you have a medical diagnosis or at least a primary-care physician aware of your symptoms — ME/CFS and Long COVID both need a clinical workup first to rule out treatable causes (thyroid, anaemia, sleep apnoea, B12 deficiency, autoimmune disease, and others). (2) Be honest about your energy envelope when you book. A good practitioner will offer a short first session (30–40 minutes) and a low-stimulation environment. (3) Ask directly: 'Have you worked with people who have ME/CFS or Long COVID before, and how do you adapt sessions?' If they don't have an answer, consider another practitioner. (4) Plan for an initial course of three to five short sessions spread over several weeks — not a tight weekly block — so you can pace around them. (5) Track PEM carefully: rate your symptoms for 48 hours before and after each session. If a session triggers PEM that takes more than 24–48 hours to settle, the dose was too high — talk to your practitioner about reducing session length or frequency. (6) Continue your existing management (pacing, medications, sleep routine, gentle movement within envelope) — CST is a complement, not a substitute.

What a typical session arc looks like: most people with ME/CFS or Long COVID who find CST useful notice small changes first — easier sleep onset, slightly less orthostatic wobbliness in the days after, a small drop in the 'wired but tired' feeling, or a sense of nervous-system settling that lasts hours or a day. These are usually modest. If you have a major flare after a session, the session was too much — that is information, not failure. The goal is the smallest useful dose, consistently, over weeks and months.